DND Pharmatech Co-Founders Exercise Stock Options to Increase Equity Stake
"Trust Reinforced by Participation of Key Figures from Mayo and Duke"
DND Pharmatech announced on March 24, 2026, that its U.S.-based co-founders have exercised their stock options to increase their equity stake in the company.
This stock option exercise included overseas researchers who have been involved with the company since its early days. These individuals have been engaged in pipeline development and global strategy planning for DND Pharmatech.
Pankaj Pasricha, Chair of the Department of Medicine at Mayo Clinic in the United States, exercised his stock options in addition to all of his existing shares. These shares are subject to a lock-up period until May 2027. Philip Phan, Professor at Johns Hopkins Carey Business School, and Michael Zalutsky, Professor of Radiology at Duke University, also participated in the stock option exercise.
A DND Pharmatech representative stated, "Considering that exercising stock options incurs taxes in the United States, the co-founders’ decision to increase their equity stake can be interpreted as a reflection of their confidence in the company’s growth potential."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
DND Pharmatech is currently developing a range of treatments, including the MASH therapy 'DD01', obesity treatments, and therapies for degenerative brain diseases. The company is also advancing both global clinical trials and commercialization efforts in parallel.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.